Copper enhances APP dimerization and promotes Aβ production.

Area of Science:

• Neuroscience
• Biochemistry
• Alzheimer's Disease Research

Background:

• Alzheimer's disease (AD) is pathologically defined by amyloid-beta (Aβ) plaque deposition.
• Amyloid precursor protein (APP) is the precursor to Aβ, cleaved by secretases.
• Elevated copper levels are found in Aβ plaques, and copper is known to enhance Aβ aggregation.

Purpose of the Study:

• To investigate the role of copper in altering amyloid precursor protein (APP) dimerization.
• To determine how copper-mediated changes in APP dimerization affect APP metabolism and Aβ production.

Main Methods:

• Investigated the effect of copper on APP dimerization.
• Assessed the impact of copper on extracellular Aβ release.
• Utilized a copper chelator, D-penicillamine, to evaluate its effects on APP dimerization and Aβ release.

Main Results:

• Copper significantly enhanced APP dimerization.
• Increased extracellular release of Aβ was observed in the presence of copper.
• D-penicillamine, a copper chelator, suppressed APP dimerization and reduced extracellular Aβ release.

Conclusions:

• Copper plays a crucial role in promoting APP dimerization.
• Copper-induced APP dimerization is linked to increased Aβ production.
• Targeting copper may represent a novel therapeutic strategy for Alzheimer's disease by modulating Aβ production pathways.